Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. 2011

Mohammadreza Bozorgmanesh, and Farzad Hadaegh, and Fereidoun Azizi
Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Sciences (RIES), Shahid Beheshti University of Medical Sciences, Tehran, Iran. mr_bozorgmanesh@endocrine.ac.ir

BACKGROUND Visceral adiposity index (VAI) has recently been developed based on waist circumference, body mass index (BMI), triglycerides (TGs), and high-density lipoprotein cholesterol (HDL-C). We examined predictive performances for incident diabetes of the VAI per se and as compared to the metabolic syndrome (MetS) and waist-to-height-ratio (WHtR). METHODS Participants free of diabetes at baseline with at least one follow-up examination (5,964) were included for the current study. Weibull regression models were developed for interval-censored survival data. Absolute and relative integrated discriminatory improvement index (IDI) and cut-point-based and cut-point-free net reclassification improvement index (NRI) were used as measures of predictive ability for incident diabetes added by VAI, as compared to the MetS and WHtR. RESULTS The annual incidence rate of diabetes was 0.85 per 1000 person. Mean VAI was 3.06 (95%CIs 2.99-3.13). Diabetes risk factors levels increased in stepwise fashion across VAI quintiles. Risk gradient between the highest and lowest quintile of VAI was 4.5 (95%CIs 3.0-6.9). VAI significantly improved predictive ability of the MetS. The relative IDI and cut-point free NRI for predictive ability added to MetS by VAI were 30.3% (95%CIs 18.8-41.8%) and 30.7% (95%CIs 20.8-40.7%), respectively. WHtR, outperformed VAI with cut-point-free NRI of 24.6% (95%CIs 14.1-35.2%). CONCLUSIONS In conclusion, although VAI could be a prognostic tool for incident diabetes events, gathering information on its components (WC, BMI, TGs, and HDL-C) is unlikely to improve the prediction ability beyond what could be achieved by the simply assessable and commonly available information on WHtR.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011237 Predictive Value of Tests In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test. Negative Predictive Value,Positive Predictive Value,Predictive Value Of Test,Predictive Values Of Tests,Negative Predictive Values,Positive Predictive Values,Predictive Value, Negative,Predictive Value, Positive
D003924 Diabetes Mellitus, Type 2 A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY. Diabetes Mellitus, Adult-Onset,Diabetes Mellitus, Ketosis-Resistant,Diabetes Mellitus, Maturity-Onset,Diabetes Mellitus, Non-Insulin-Dependent,Diabetes Mellitus, Slow-Onset,Diabetes Mellitus, Stable,MODY,Maturity-Onset Diabetes Mellitus,NIDDM,Diabetes Mellitus, Non Insulin Dependent,Diabetes Mellitus, Noninsulin Dependent,Diabetes Mellitus, Noninsulin-Dependent,Diabetes Mellitus, Type II,Maturity-Onset Diabetes,Noninsulin-Dependent Diabetes Mellitus,Type 2 Diabetes,Type 2 Diabetes Mellitus,Adult-Onset Diabetes Mellitus,Diabetes Mellitus, Adult Onset,Diabetes Mellitus, Ketosis Resistant,Diabetes Mellitus, Maturity Onset,Diabetes Mellitus, Slow Onset,Diabetes, Maturity-Onset,Diabetes, Type 2,Ketosis-Resistant Diabetes Mellitus,Maturity Onset Diabetes,Maturity Onset Diabetes Mellitus,Non-Insulin-Dependent Diabetes Mellitus,Noninsulin Dependent Diabetes Mellitus,Slow-Onset Diabetes Mellitus,Stable Diabetes Mellitus
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D012307 Risk Factors An aspect of personal behavior or lifestyle, environmental exposure, inborn or inherited characteristic, which, based on epidemiological evidence, is known to be associated with a health-related condition considered important to prevent. Health Correlates,Risk Factor Scores,Risk Scores,Social Risk Factors,Population at Risk,Populations at Risk,Correlates, Health,Factor, Risk,Factor, Social Risk,Factors, Social Risk,Risk Factor,Risk Factor Score,Risk Factor, Social,Risk Factors, Social,Risk Score,Score, Risk,Score, Risk Factor,Social Risk Factor
D014781 Viscera Any of the large interior organs in any one of the three great cavities of the body, especially in the abdomen.
D050154 Adiposity The amount of fat or lipid deposit at a site or an organ in the body, an indicator of body fat status.

Related Publications

Mohammadreza Bozorgmanesh, and Farzad Hadaegh, and Fereidoun Azizi
January 2022, Journal of Ayub Medical College, Abbottabad : JAMC,
Mohammadreza Bozorgmanesh, and Farzad Hadaegh, and Fereidoun Azizi
May 2015, Herz,
Mohammadreza Bozorgmanesh, and Farzad Hadaegh, and Fereidoun Azizi
January 2021, Diabetes, metabolic syndrome and obesity : targets and therapy,
Mohammadreza Bozorgmanesh, and Farzad Hadaegh, and Fereidoun Azizi
February 2021, Diabetes/metabolism research and reviews,
Mohammadreza Bozorgmanesh, and Farzad Hadaegh, and Fereidoun Azizi
March 2022, Diabetes/metabolism research and reviews,
Mohammadreza Bozorgmanesh, and Farzad Hadaegh, and Fereidoun Azizi
January 2014, PloS one,
Mohammadreza Bozorgmanesh, and Farzad Hadaegh, and Fereidoun Azizi
January 2019, Diabetes & metabolic syndrome,
Mohammadreza Bozorgmanesh, and Farzad Hadaegh, and Fereidoun Azizi
April 2024, Nutrition, metabolism, and cardiovascular diseases : NMCD,
Mohammadreza Bozorgmanesh, and Farzad Hadaegh, and Fereidoun Azizi
August 2020, Medicine,
Mohammadreza Bozorgmanesh, and Farzad Hadaegh, and Fereidoun Azizi
April 2000, Diabetes care,
Copied contents to your clipboard!